Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse

Pediatric Research

Volumn 72, Issue 5, 2012, Pages 502-506

  Weisman, Leonard E ^a   Leeming, Angela H ^a   Kong, Lingkun ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS GROWTH; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; UREAPLASMA; UREAPLASMA INFECTION;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTEREMIA; DISEASE MODELS, ANIMAL; ERYTHROMYCIN; FEMALE; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; PREGNANCY; SEPSIS; UREAPLASMA; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 84870522126     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.115     Document Type: Article

References (36)

1. Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 1993;6:69-87. (Pubitemid 23055195)
2. Katz B, Patel P, Duffy L, Schelonka RL, Dimmitt RA, Waites KB. Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia. J Clin Microbiol 2005;43: 4852-4. (Pubitemid 41298293)
3. Zheng X, Watson HL, Waites KB, Cassell GH. Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates. Infect Immun 1992;60:3472-4.
4. Berger A, Witt A, Haiden N, Kretzer V, Heinze G, Pollak A. Amniotic cavity cultures, blood cultures, and surface swabs in preterm infants-useful tools for the management of early-onset sepsis? J Perinat Med 2004;32:446-52. (Pubitemid 39304417)
5. Cassell GH, Waites KB, Crouse DT, et al. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet 1988;2: 240-5.
6. Goldenberg RL, Andrews WW, Goepfert AR, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 2008;198:43. e1-5.
7. Brus F, van Waarde WM, Schoots C, Oetomo SB. Fatal ureaplasmal pneumonia and sepsis in a newborn infant. Eur J Pediatr 1991;150:782-3.
8. Fonseca LT, Silveira RC, Procianoy RS. Ureaplasma bacteremia in very low birth weight infants in Brazil. Pediatr Infect Dis J 2011;30:1052-5.
9. Morioka I, Fujibayashi H, Enoki E, Yokoyama N, Yokozaki H, Matsuo M. Congenital pneumonia with sepsis caused by intrauterine infection of Ureaplasma parvum in a term newborn: a first case report. J Perinatol 2010;30:359-62.
10. Viscardi RM, Hashmi N, Gross GW, Sun CC, Rodriguez A, Fairchild KD. Incidence of invasive ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage. J Perinatol 2008;28:759-65.
11. Waites KB, Crouse DT, Philips JB III, Canupp KC, Cassell GH. Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn. Pediatrics 1989;83:79-85.
12. Waites KB, Rudd PT, Crouse DT, et al. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet 1988;1:17-21. (Pubitemid 18017204)
13. Heggie AD, Jacobs MR, Butler VT, Baley JE, Boxerbaum B. Frequency and significance of isolation of Ureaplasma urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal aspirate specimens from low birth weight infants. J Pediatr 1994;124:956-61. (Pubitemid 24184028)
14. Sethi S, Sharma M, Narang A, Aggrawal PB. Isolation pattern and clinical outcome of genital mycoplasma in neonates from a tertiary care neonatal unit. J Trop Pediatr 1999;45:143-5. (Pubitemid 29267565)
15. Waites KB, Crouse DT, Cassell GH. Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates. Pediatr Infect Dis J 1992;11:23-9.
16. Tay ST, Boo NY, Khoo TB, Koay AS, Rohani MY. Prevalence and antibiotic susceptibility of Ureaplasma urealyticum in Malaysian neonates with respiratory distress. Med J Malaysia 1997;52:409-11. (Pubitemid 28240147)
17. Matlow A, Th'ng C, Kovach D, Quinn P, Dunn M, Wang E. Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. Antimicrob Agents Chemother 1998;42:1290-2. (Pubitemid 28227941)
18. Mabanta CG, Pryhuber GS, Weinberg GA, Phelps DL. Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev 2003:CD003744.
19. Baier RJ, Loggins J, Kruger TE. Failure of erythromycin to eliminate airway colonization with ureaplasma urealyticum in very low birth weight infants. BMC Pediatr 2003;3:10.
20. Bayraktar MR, Ozerol IH, Gucluer N, Celik O. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis 2010;14:e90-5.
21. Walls SA, Kong L, Leeming HA, Placencia FX, Popek EJ, Weisman LE. Antibiotic prophylaxis improves Ureaplasma-associated lung disease in suckling mice. Pediatr Res 2009;66:197-202.
22. Pinna GS, Skevaki CL, Kafetzis DA. The significance of Ureaplasma urealyticum as a pathogenic agent in the paediatric population. Curr Opin Infect Dis 2006;19:283-9. (Pubitemid 43740368)
23. Ballard HO, Shook LA, Bernard P, et al. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial. Pediatr Pulmonol 2011;46:111-8.
24. Ozdemir R, Erdeve O, Dizdar EA, et al. Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants. Pediatrics 2011;128:e1496-501.
25. Clifford V, Tebruegge M, Everest N, Curtis N. Ureaplasma: pathogen or passenger in neonatal meningitis? Pediatr Infect Dis J 2010;29:60-4.
26. Beeton ML, Chalker VJ, Maxwell NC, Kotecha S, Spiller OB. Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance. Antimicrob Agents Chemother 2009;53:2020-7.
27. Ballard HO, Bernard P, Qualls J, Everson W, Shook LA. Azithromycin protects against hyperoxic lung injury in neonatal rats. J Investig Med 2007;55:299-305. (Pubitemid 350205424)
28. Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol 2012;68:479-503.
29. Kasper DC, Mechtler TP, Reischer GH, et al. The bacterial load of Ureaplasma parvum in amniotic fluid is correlated with an increased intrauterine inflammatory response. Diagn Microbiol Infect Dis 2010;67:117-21.
30. Yi J, Yoon BH, Kim EC. Detection and biovar discrimination of Ureaplasma urealyticum by real-time PCR. Mol Cell Probes 2005;19:255-60. (Pubitemid 40982568)
31. Kim M, Kim G, Romero R, Shim SS, Kim EC, Yoon BH. Biovar diversity of Ureaplasma urealyticum in amniotic fluid: distribution, intrauterine inflammatory response and pregnancy outcomes. J Perinat Med 2003;31:146-52. (Pubitemid 36541883)
32. Martínez MA, Ovalle A, Santa-Cruz A, Barrera B, Vidal R, Aguirre R. Occurrence and antimicrobial susceptibility of Ureaplasma parvum (Ureaplasma urealyticum biovar 1) and Ureaplasma urealyticum (Ureaplasma urealyticum biovar 2) from patients with adverse pregnancy outcomes and normal pregnant women. Scand J Infect Dis 2001;33:604-10. (Pubitemid 32776349)
33. Kong F, Ma Z, James G, Gordon S, Gilbert GL. Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCRbased assays. J Clin Microbiol 2000;38:1175-9. (Pubitemid 30140579)
34. Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 2005;18:757-89. (Pubitemid 41504514)
35. Waites KB, Crabb DM, Duffy LB. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother 2003;47:3973-5. (Pubitemid 37485019)
36. Rudd PT, Cassell GH, Waites KB, Davis JK, Duffy LB. Ureaplasma urealyticum pneumonia: experimental production and demonstration of agerelated susceptibility. Infect Immun 1989;57:918-25. (Pubitemid 19064560).